A new scoring system uses readily available demographic and laboratory data to identify patients with higher risk for advanced fibrosis.
Several noninvasive scoring systems are used to identify advanced fibrosis in nonalcoholic-fatty-liver-disease (NAFLD) patients. These systems help to avoid liver biopsies, but some use proprietary assays (see NEJM JW Gastroenterology Feb 2019 and Clin Gastroenterol Hepatol 2018 Nov 21; [e-pub]), some require specialized equipment (transient elastography), and others have moderate accuracy and variable performance depending on patient characteristics (NAFLD fibrosis score [NFS] and FIB-4).
These authors devised the Hepamet Fibrosis scoring system, a noninvasive system using readily available standard variables. They compared it with NFS and FIB-4 scoring methods for identifying advanced fibrosis in an international cross-sectional study of n…
Reviewing Author
DisclosuresNothing to disclose
DisclosuresNothing to disclose